Effects of 1 year treatment with pioglitazione vs sulfonylurea on lipid metabolism in type 2 diabetes patients

被引：0
|
作者：
Russo, M. [1 ,2 ]
Carli, F. [1 ]
Vitale, M. [3 ]
Masulli, M. [3 ]
Bozzetto, L. [3 ]
Della Pepa, G. [3 ]
Pezzica, S. [1 ]
Vaccaro, O. [3 ]
Rivellese, A. [3 ]
Gastaldelli, A. [1 ]
机构：
[1] CNR, Inst Clin Physiol, Pisa, Italy
[2] Univ Siena, Siena, Italy
[3] Univ Naples Federico II, Naples, Italy
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
619
引用
收藏
页码：S298 / S298
页数：1
相关论文
共 50 条
  • [41] Effects of physiological vs non-physiological restoration of postprandial insulin secretion on glucose and lipid metabolism in type 2 diabetes
    Lambadiari, V.
    Dimitriadis, G.
    Boutati, E.
    Mitrou, P.
    Maratou, E.
    Raptis, S. A.
    DIABETOLOGIA, 2006, 49 : 341 - 342
  • [42] Effects of Type 2 Diabetes Mellitus in Patients on Treatment With Glibenclamide and Metformin on Carvedilol Enantiomers Metabolism
    Nardotto, Glauco H. B.
    Coelho, Eduardo B.
    Paiva, Carlos E.
    Lanchote, Vera L.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (06): : 760 - 769
  • [43] Treatment with marine collagen peptides modulates glucose and lipid metabolism in Chinese patients with type 2 diabetes mellitus
    Zhu, Cui-Feng
    Li, Guan-Zhi
    Peng, Hong-Bin
    Zhang, Fan
    Chen, Yun
    Li, Yong
    APPLIED PHYSIOLOGY NUTRITION AND METABOLISM, 2010, 35 (06) : 797 - 804
  • [44] Pioglitazone in combination with sulfonylurea results in changes in lipid subspecies and subparticle profiles in patients with Type 2 diabetes.
    Murray, FT
    Perez, A
    Johnson, T
    Karunaratne, M
    DIABETOLOGIA, 2003, 46 : A354 - A355
  • [45] Effects of telmisartan compared to nifedipine in hypertensive, type 2 diabetic patients on glucose metabolism and lipid profile: a 1-year study
    Derosa, G
    Mugellini, A
    Dodi, C
    Ciccarelli, L
    Fogari, R
    DIABETES, 2003, 52 : A445 - A445
  • [46] Search for Pharmacoepigenetic Correlations in Type 2 Diabetes Under Sulfonylurea Treatment
    Karaglani, Makrina
    Ragia, Georgia
    Panagopoulou, Maria
    Balgkouranidou, Ioanna
    Nena, Evangelia
    Kolios, George
    Papanas, Nikolaos
    Manolopoulos, Vangelis G.
    Chatzaki, Ekaterini
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2019, 127 (04) : 226 - 233
  • [47] Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes
    Derosa, G.
    Cicero, A. F. G.
    D'Angelo, A.
    Fogari, E.
    Maffioli, P.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (02) : 187 - 195
  • [48] Effects of 1-year treatment with canagliflozin on body composition and total body water in patients with type 2 diabetes
    Matsuba, Ikuro
    Takihata, Masahiro
    Takai, Masahiko
    Maeda, Hajime
    Kubota, Akira
    Iemitsu, Kotaro
    Umezawa, Shinichi
    Obana, Mitsuo
    Kaneshiro, Mizuki
    Kawata, Takehiro
    Takuma, Tetsuo
    Takeda, Hiroshi
    Machimura, Hideo
    Mokubo, Atsuko
    Motomiya, Tetsuya
    Asakura, Taro
    Kikuchi, Taisuke
    Matsuzawa, Yoko
    Ito, Shogo
    Miyakawa, Masaaki
    Terauchi, Yasuo
    Kanamori, Akira
    DIABETES OBESITY & METABOLISM, 2021, 23 (12): : 2614 - 2622
  • [49] Effects of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Postprandial Lipid Metabolism in Patients with Type 2 Diabetes
    Ahn, Chang Ho
    Kim, Eun Ky
    Kim, Lee Kyung
    Min, Se Hee
    Bae, Jae Hyun
    Park, Kyong Soo
    Cho, Young Min
    DIABETES, 2016, 65 : A577 - A577
  • [50] Glimepiride: Role of a new sulfonylurea in the treatment of type 2 diabetes mellitus
    Campbell, RK
    ANNALS OF PHARMACOTHERAPY, 1998, 32 (10) : 1044 - 1052
12345